These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 37848268)

  • 1. Estimated health benefits, costs and cost-effectiveness of eliminating dietary industrial trans fatty acids in Kenya: cost-effectiveness analysis.
    Marklund M; Aminde LN; Wanjau MN; Huang L; Awuor C; Steele L; Cobb LK; Veerman JL; Wu JH
    BMJ Glob Health; 2023 Oct; 8(10):. PubMed ID: 37848268
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Estimated health benefits, costs and cost-effectiveness of eliminating industrial trans
    Marklund M; Aminde LN; Wanjau MN; Ale BM; Ojo AE; Okoro CE; Adegboye A; Huang L; Veerman JL; Wu JH; Huffman MD; Ojji DB
    BMJ Glob Health; 2024 Apr; 9(4):. PubMed ID: 38631705
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Estimated health benefits, costs, and cost-effectiveness of eliminating industrial trans-fatty acids in Australia: A modelling study.
    Marklund M; Zheng M; Veerman JL; Wu JHY
    PLoS Med; 2020 Nov; 17(11):e1003407. PubMed ID: 33137090
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cost-effectiveness of financial incentives and disincentives for improving food purchases and health through the US Supplemental Nutrition Assistance Program (SNAP): A microsimulation study.
    Mozaffarian D; Liu J; Sy S; Huang Y; Rehm C; Lee Y; Wilde P; Abrahams-Gessel S; de Souza Veiga Jardim T; Gaziano T; Micha R
    PLoS Med; 2018 Oct; 15(10):e1002661. PubMed ID: 30278053
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cost-effectiveness Analysis of Nutrition Facts Added-Sugar Labeling and Obesity-Associated Cancer Rates in the US.
    Du M; Griecci CF; Cudhea FF; Eom H; Kim DD; Wilde P; Wong JB; Wang YC; Michaud DS; Mozaffarian D; Zhang F;
    JAMA Netw Open; 2021 Apr; 4(4):e217501. PubMed ID: 33904914
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development and application of the TFA macrosimulation model: a case study of modelling the impact of trans fatty acid (TFA) elimination policies in Brazil.
    Nilson EAF; Khandpur N; da Silva Gomes F
    BMC Public Health; 2022 Nov; 22(1):2010. PubMed ID: 36324096
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Public health economic evaluation of different European Union-level policy options aimed at reducing population dietary trans fat intake.
    Martin-Saborido C; Mouratidou T; Livaniou A; Caldeira S; Wollgast J
    Am J Clin Nutr; 2016 Nov; 104(5):1218-1226. PubMed ID: 27680991
    [TBL] [Abstract][Full Text] [Related]  

  • 8. What is the cost-effectiveness of menu calorie labelling on reducing obesity-associated cancer burdens? An economic evaluation of a federal policy intervention among 235 million adults in the USA.
    Du M; Griecci CF; Cudhea F; Eom H; Wong JB; Wilde P; Kim DD; Michaud DS; Wang YC; Mozaffarian D; Zhang FF;
    BMJ Open; 2023 Apr; 13(4):e063614. PubMed ID: 37072239
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Potential of trans fats policies to reduce socioeconomic inequalities in mortality from coronary heart disease in England: cost effectiveness modelling study.
    Allen K; Pearson-Stuttard J; Hooton W; Diggle P; Capewell S; O'Flaherty M
    BMJ; 2015 Sep; 351():h4583. PubMed ID: 26374614
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cost-effectiveness of financial incentives for improving diet and health through Medicare and Medicaid: A microsimulation study.
    Lee Y; Mozaffarian D; Sy S; Huang Y; Liu J; Wilde PE; Abrahams-Gessel S; Jardim TSV; Gaziano TA; Micha R
    PLoS Med; 2019 Mar; 16(3):e1002761. PubMed ID: 30889188
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cost-Effectiveness of the US Food and Drug Administration Added Sugar Labeling Policy for Improving Diet and Health.
    Huang Y; Kypridemos C; Liu J; Lee Y; Pearson-Stuttard J; Collins B; Bandosz P; Capewell S; Whitsel L; Wilde P; Mozaffarian D; O'Flaherty M; Micha R;
    Circulation; 2019 Jun; 139(23):2613-2624. PubMed ID: 30982338
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The health and economic impact and cost effectiveness of interventions for the prevention and control of overweight and obesity in Kenya: a stakeholder engaged modelling study.
    Wanjau MN; Kivuti-Bitok LW; Aminde LN; Veerman JL
    Cost Eff Resour Alloc; 2023 Sep; 21(1):69. PubMed ID: 37735408
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Health and Economic Impacts of the National Menu Calorie Labeling Law in the United States: A Microsimulation Study.
    Liu J; Mozaffarian D; Sy S; Lee Y; Wilde PE; Abrahams-Gessel S; Gaziano T; Micha R;
    Circ Cardiovasc Qual Outcomes; 2020 Jun; 13(6):e006313. PubMed ID: 32493057
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Health Impact and Cost-Effectiveness of Achieving the National Salt and Sugar Reduction Initiative Voluntary Sugar Reduction Targets in the United States: A Microsimulation Study.
    Shangguan S; Mozaffarian D; Sy S; Lee Y; Liu J; Wilde PE; Sharkey AL; Dowling EA; Marklund M; Abrahams-Gessel S; Gaziano TA; Micha R
    Circulation; 2021 Oct; 144(17):1362-1376. PubMed ID: 34445886
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Eliminating artificial trans fatty acids in Argentina: estimated effects on the burden of coronary heart disease and costs.
    Rubinstein A; Elorriaga N; Garay OU; Poggio R; Caporale J; Matta MG; Augustovski F; Pichon-Riviere A; Mozaffarian D
    Bull World Health Organ; 2015 Sep; 93(9):614-22. PubMed ID: 26478625
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Taxes and Subsidies for Improving Diet and Population Health in Australia: A Cost-Effectiveness Modelling Study.
    Cobiac LJ; Tam K; Veerman L; Blakely T
    PLoS Med; 2017 Feb; 14(2):e1002232. PubMed ID: 28196089
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cost-effectiveness of PCSK9 Inhibitor Therapy in Patients With Heterozygous Familial Hypercholesterolemia or Atherosclerotic Cardiovascular Disease.
    Kazi DS; Moran AE; Coxson PG; Penko J; Ollendorf DA; Pearson SD; Tice JA; Guzman D; Bibbins-Domingo K
    JAMA; 2016 Aug; 316(7):743-53. PubMed ID: 27533159
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cost-effectiveness of rotavirus vaccination in Kenya and Uganda.
    Sigei C; Odaga J; Mvundura M; Madrid Y; Clark AD; ;
    Vaccine; 2015 May; 33 Suppl 1():A109-18. PubMed ID: 25919149
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.